Brinzolamide Powder
Product Images NDC 62207-011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brinzolamide (NDC 62207-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4987e688 4c55 2d5c E054 00144ff8d46c

Brinzolamide is a medication identified as USP and is stored in a container with a capacity of 000. The details of the weight and related details of this medication are also available on the container. The medication needs to be stored in a place with the right environmental conditions to preserve its effectiveness. Granules India Limited is the manufacturer of this product and is based in Andha Pradesh, India.*

FDA Label Image

62207-011-01 (62207 011 01)

This is a description of a medication called Brinzolamide, USP, which includes the batch number, container number, manufacturing date and expiration date, net and gross weight, and NDC number. It also provides storage instructions and country of origin, which is India. The medication is cautionary and only meant for manufacturing, processing, or repacking under the label "Rx". The manufacturer of the granules is Granules India Limited, located at Unit-IV in Visakhapatnam, Andhra Pradesh, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.